Catalent, Inc. Profile Avatar - Palmy Investing

Catalent, Inc.

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Techno…
Drug Manufacturers - Specialty & Generic
US, Somerset [HQ]
CTLT/Financials
Segments · Problems · Premarket · Compliance

Segment Analysis

Segment Analysis
Revenue · By Business Segment
Not available for CTLT
Revenue · By Area
Not available for CTLT
End of CTLT's Analysis
CIK: 1596783 CUSIP: 148806102 ISIN: US1488061029 LEI: - UEI: -
Secondary Listings
CTLT has no secondary listings inside our databases.